Press and Public Relations

Joint International Journal of Cancer and Klaus Tschira Stiftung Lecture at DKFZ

Wednesday, October 17, 2012 - Dr. Max S. Wicha

Dr. Wicha has been a pioneering force in cancer stem cell biology, and his group was the first to identify breast cancer stem cells. His laboratory identified a number of stem cell markers and developed in vitro and mouse models to isolate and characterize these cells, models which have been widely used in the field. Subsequently his laboratory elucidated a number of intrinsic and extrinsic pathways which regulate self-renewal and cell fate decisions in these cells. Recently, he has focused on translating his preclinical research into the development of clinical trials designed to target breast cancer stem cells.

Max Wicha did his undergraduate work in biology at the State University of New York at Stony Brook and his graduate studies in medicine at Stanford University School of Medicine, California, receiving his M.D. in 1974. After an internship and residency in internal medicine at the University of Chicago, he spent several years at NIH as a fellow in clinical oncology and research associate and investigator in the laboratory of pathophysiology at NIC. In 1980 Dr. Wicha accepted a professorship at the University of Michigan in Ann Arbor, where he been since. He is the founding and current Director of the University of Michigan’s Comprehensive Cancer Center (UMCCC), a position he has held continuously for 25 years. Under his leadership, UMCCC established itself as a world-renowned center for cancer care.

Dr. Wicha is among the most highly cited investigators in the field of cancer stem cells. An extensive list of high-profile research articles, reviews, and book chapters speak for this. He is highly sought after internationally as speaker, advisor, and reviewer.


Dr. Max S. Wicha interviewed by Dr. Stefanie Seltmann

to top